Cargando…
Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. Understanding the cancer mechanisms provides novel diagnostic, prognostic, and therapeutic markers for the management of HCC disease. In addition to genomic and epigenomic regulation, post-translational modification...
Autores principales: | Wang, Yifei, Chen, Huarong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256610/ https://www.ncbi.nlm.nih.gov/pubmed/37193819 http://dx.doi.org/10.1038/s41388-023-02702-w |
Ejemplares similares
-
Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells
por: Liu, Tianhua, et al.
Publicado: (2017) -
Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications
por: Zhu, Xinqing, et al.
Publicado: (2022) -
Tumor‐Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma
por: Alcedo, Karel P., et al.
Publicado: (2019) -
Evolutional and clinical implications of the epigenetic regulation of protein glycosylation
por: Horvat, Tomislav, et al.
Publicado: (2011) -
MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications
por: Sun, Jie, et al.
Publicado: (2013)